Dr. Jose M. Echeverria, MD

Dr. Echeverria practices at Arh Daniel Boone Clinic Harlan - Primary Care - HOPD in Harlan, Kentucky.

Dr. Echeverria's NPI, 1215929575, was assigned on August 22, 2005. Dr. Echeverria holds Kentucky license 32446.

Dr. Echeverria's primary practice is Arh Daniel Boone Clinic Harlan - Primary Care - HOPD, at 37 Ball Park Rd, Harlan, KY 40831.

Dr. Echeverria's primary practice is Arh Daniel Boone Clinic Harlan - Primary Care - HOPD in Harlan, Kentucky. Dr. Echeverria is also affiliated with Harlan ARH Hospital. The medical group on file is ARH Pennington Gap Clinic. Dmand AI also links Dr. Echeverria to 1 more home health agency and 1 rural health clinic, each named with a free account. Dr. Echeverria's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Echeverria practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Echeverria's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Echeverria is licensed in Kentucky.

CMS data shows 244 Medicare services from Dr. Echeverria across 6 procedure codes in 2024, for 56 Medicare patients. Medicare paid $16,486 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Dr. Echeverria in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Echeverria's median patient age at 63, with 51% women.

In 2024, Dr. Echeverria wrote 17,159 Medicare Part D claims for 465 patients. 89% of them were for generic drugs. CMS names the drug for 16,689 of them, across 191 drugs with 11 or more claims each, at $719,890 in total drug cost. In 2023, CMS named 17,333 claims across 190 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Echeverria for performance year 2024, reported through an alternative payment model (APM). Dr. Echeverria accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 31 general payments to Dr. Echeverria from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Smith & Nephew, Inc. paid the most, $79.